Banque Cantonale Vaudoise’s Madrigal Pharmaceuticals MDGL Stock Holding History

Banque Cantonale Vaudoise’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$565	Buy	1,052 +190	+22%	+$97.3K	﹤0.01%	514
2026 Q1	$451K	Buy	+862	New	+$412K	0.02%	511
2022 Q1	–	Sell	-1,500	Closed	-$127K	–	1356
2021 Q4	$127K	Hold	1,500	–	–	0.01%	919
2021 Q3	$120K	Hold	1,500	–	–	0.01%	908
2021 Q2	$146K	Hold	1,500	–	–	0.01%	896
2021 Q1	$175K	Hold	1,500	–	–	0.01%	802
2020 Q4	$167K	Hold	1,500	–	–	0.01%	762
2020 Q3	$178K	Buy	+1,500	New	+$163K	0.01%	715

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Banque Cantonale Vaudoise's MDGL Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its Madrigal Pharmaceuticals (MDGL) stake by 22% in Q2 2026, buying an estimated $97.3K and bringing the position to 1,052 shares worth $565. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Banque Cantonale Vaudoise first reported a position in MDGL in Q3 2020 and has held it in 8 quarters since. The position peaked at $451K in Q1 2026. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Banque Cantonale Vaudoise held 1,052 shares of Madrigal Pharmaceuticals worth $565 as of Q2 2026.
Banque Cantonale Vaudoise bought 190 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $97.3K.
Madrigal Pharmaceuticals made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #514 holding.
Banque Cantonale Vaudoise first reported a position in Madrigal Pharmaceuticals in Q3 2020 and has held it in 8 quarters since.
Banque Cantonale Vaudoise's Madrigal Pharmaceuticals position peaked at $451K in Q1 2026.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.